Back to search

University of Alabama Birmingham

Effect Of Pre-Treatment Lab-Based Comorbidities On Treatment Related Outcomes Among Patients With Cancer

Abstract

dc:description.abstract

Cancer is one of the leading causes of mortality and morbidity in the United States. In addition to their cancer, nearly 50% of individuals have a comorbid condition. This adds complexity to the treatment of these patients as it may delay cancer diagnosis or treatment or prevent treatment all together. Lab-values are an important tool to measure comorbidities and end-organ damage as they are routinely captured as part of standard of care and the basis of clinician decision making. However, despite the widespread multimorbidity and how crucial they are to decision making, few studies assess the association of lab abnormalities with treatment outcomes. In addition, clinical trials often exclude patients with lab abnormalities despite these patients potentially receiving the treatment after it is put on the market. There have been many calls to broaden exclusion criteria in respect to lab-values in cancer clinical trials. Therefore, this dissertation contains three research projects to better understand the relationship between routinely captured lab-values and treatment-related outcomes in patients with cancer. First, we will compare the time-to-treatment discontinuation and overall survival for those with and without lab abnormalities. Second, we will examine an optimal cut-point at which an abnormal lab-value is associated with worsening symptoms after cancer treatment initiation. Third, we will use lab values alongside other patient demographic and clinical information to create patient profiles and assess these profiles for risks of dose modifications. These contributions will help in our understanding of how patients with lab-abnormalities fair on their cancer treatment and provide more crucial information in the call to modernize cancer clinical trials.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy (PhD)
Level thesis:degree_level
Dissertation
Discipline thesis:degree_discipline
Epidemiology

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Franks, Jeffrey Alan
Contributors dc:contributor
  • <p>Russell Griffin</p>
  • <p>Andres Azuero<br>Gabrielle Rocque<br>Kelly Kenzik<br>MacKenzie Fowler</p>
  • Gabrielle Rocque

Subjects

dc:subject × 3

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
University of Alabama Birmingham
Base URL
digitalcommons.library.uab.edu/do/oai/
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Franks, Jeffrey Alan. Effect Of Pre-Treatment Lab-Based Comorbidities On Treatment Related Outcomes Among Patients With Cancer. Dissertation thesis, https://digitalcommons.library.uab.edu/etd-collection/6836